{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:24:40Z","timestamp":1780705480785,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.euroneuro.2021.02.010","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T09:41:43Z","timestamp":1616060503000},"page":"28-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study"],"prefix":"10.1016","volume":"46","author":[{"given":"Kirsten C","family":"Morley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren B","family":"Logge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.euroneuro.2021.02.010_bib0001","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/alcalc\/37.5.504","article-title":"Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study","volume":"37","author":"Addolorato","year":"2002","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.euroneuro.2021.02.010_bib0002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fpsyt.2018.00464","article-title":"Baclofen in the treatment of patients with alcohol use disorder and other mental health disorders","volume":"9","author":"Agabio","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"12","key":"10.1016\/j.euroneuro.2021.02.010_bib0003","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S2215-0366(18)30303-1","article-title":"The use of baclofen to treat patients with alcohol use disorder: the cagliari expert consensus statement","volume":"5","author":"Agabio","year":"2018","journal-title":"The Lancet Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2021.02.010_bib0004","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/npp.2011.32","article-title":"Pregabalin influences insula and amygdala activation during anticipation of emotional images","volume":"36","author":"Aupperle","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.euroneuro.2021.02.010_bib0005","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.euroneuro.2018.08.507","article-title":"Effects of high-dose baclofen on cue reactivity in alcohol dependence: a randomized, placebo-controlled pharmaco-fMRI study","volume":"28","author":"Beck","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.euroneuro.2021.02.010_bib0006","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.euroneuro.2016.10.006","article-title":"Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: a multicentre, randomised, double-blind controlled trial","volume":"26","author":"Beraha","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.02.010_bib0007","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1037\/0021-843X.99.4.344","article-title":"Severity of psychosocial stress and outcome of alcoholism treatment","volume":"99","author":"Brown","year":"1990","journal-title":"J. Abnorm. Psychol."},{"issue":"12","key":"10.1016\/j.euroneuro.2021.02.010_bib0008","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S2215-0366(19)30222-6","article-title":"Psychiatric comorbidities in alcohol use disorder","volume":"6","author":"Castillo-Carniglia","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.02.010_bib0009","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0269881111408463","article-title":"Substitution therapy for alcoholism: time for a reappraisal?","volume":"26","author":"Chick","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.euroneuro.2021.02.010_bib0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/79871","article-title":"Subcortical and cortical brain activity during the feeling of self-generated emotions","volume":"3","author":"Damasio","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.02.010_bib0011","doi-asserted-by":"crossref","first-page":"9908","DOI":"10.1038\/s41598-018-28321-0","article-title":"Baclofen acts in the central amygdala to reduce synaptic transmission and impair context fear conditioning","volume":"8","author":"Delaney","year":"2018","journal-title":"Sci. Rep."},{"issue":"28","key":"10.1016\/j.euroneuro.2021.02.010_bib0012","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1073\/pnas.1602413113","article-title":"Cluster failure: why fMRI inferences for spatial extent have inflated false-positive rates","volume":"113","author":"Eklund","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2021.02.010_bib0013","doi-asserted-by":"crossref","first-page":"e1108","DOI":"10.1038\/tp.2017.71","article-title":"Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study","volume":"7","author":"Farokhnia","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.02.010_bib0014","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuropharm.2018.04.011","article-title":"Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: results from a combined outpatient and human laboratory experiment","volume":"137","author":"Farokhnia","year":"2018","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.euroneuro.2021.02.010_bib0015","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","article-title":"Psychometric properties of the Penn alcohol craving scale","volume":"23","author":"Flannery","year":"1999","journal-title":"Alcoholism"},{"issue":"11","key":"10.1016\/j.euroneuro.2021.02.010_bib0016","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/imj.13237","article-title":"Alcohol use disorders in Australia","volume":"46","author":"Freyer","year":"2016","journal-title":"Intern Med. J."},{"issue":"11","key":"10.1016\/j.euroneuro.2021.02.010_bib0017","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","article-title":"Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcoholism"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.02.010_bib0018","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0043-124189","article-title":"Hypothalamic-pituitary-adrenocortical axis activity in alcohol-dependent patients during treatment with high-dose baclofen","volume":"52","author":"Geisel","year":"2019","journal-title":"Pharmacopsychiatry"},{"issue":"18","key":"10.1016\/j.euroneuro.2021.02.010_bib0019","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1523\/JNEUROSCI.0086-08.2008","article-title":"Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol","volume":"28","author":"Gilman","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.02.010_bib0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1369-1600.2008.00136.x","article-title":"Identifying the neural circuitry of alcohol craving and relapse vulnerability","volume":"14","author":"Heinz","year":"2009","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.02.010_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-011-2236-1","article-title":"Stressful life experiences, alcohol consumption, and alcohol use disorders: the epidemiologic evidence for four main types of stressors","volume":"218","author":"Keyes","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.euroneuro.2021.02.010_bib0022","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance use disorders: a reconsideration and recent applications","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harv Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.02.010_bib0023","series-title":"International Affective Picture System (IAPS): Technical manual and Affective Ratings","author":"Lang","year":"1999"},{"key":"10.1016\/j.euroneuro.2021.02.010_bib0024","article-title":"Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals","author":"Logge","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2021.02.010_bib0025","series-title":"Manual For the Depression Anxiety Stress Scales","author":"Lovibond","year":"1995"},{"issue":"11","key":"10.1016\/j.euroneuro.2021.02.010_bib0026","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s40263-013-0092-8","article-title":"Neural bases of pharmacological treatment of nicotine dependence - insights from functional brain imaging: a systematic review","volume":"27","author":"Menossi","year":"2013","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.02.010_bib0027","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuropharm.2011.08.040","article-title":"The GABA system in anxiety and depression and its therapeutic potential","volume":"62","author":"Mohler","year":"2012","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.euroneuro.2021.02.010_bib0028","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.npp.1300413","article-title":"Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior","volume":"29","author":"Mombereau","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.02.010_bib0029","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001756-200502280-00021","article-title":"Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits","volume":"16","author":"Mombereau","year":"2005","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/j.euroneuro.2021.02.010_bib0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1192\/bjp.2018.13","article-title":"Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial","volume":"212","author":"Morley","year":"2018","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2021.02.010_bib0031","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/alcalc\/agu062","article-title":"Baclofen for the treatment of alcohol dependence and possible role of comorbid anxiety","volume":"49","author":"Morley","year":"2014","journal-title":"Alcohol Alcohol"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.02.010_bib0032","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cct.2013.08.002","article-title":"The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial","volume":"36","author":"Morley","year":"2013","journal-title":"Contemp Clin. Trials"},{"key":"10.1016\/j.euroneuro.2021.02.010_bib0033","doi-asserted-by":"crossref","DOI":"10.1080\/14656566.2021.1892641","article-title":"New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies","author":"Morley","year":"2021","journal-title":"Expert Opinion Pharm"},{"issue":"8","key":"10.1016\/j.euroneuro.2021.02.010_bib0034","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.euroneuro.2015.04.002","article-title":"High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial","volume":"25","author":"M\u00fcller","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.euroneuro.2021.02.010_bib0035","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/npp.2012.77","article-title":"Withdrawal-associated increases and decreases in functional neural connectivity associated with altered emotional regulation in alcoholism","volume":"37","author":"O'Daly","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.euroneuro.2021.02.010_bib0036","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.euroneuro.2018.03.017","article-title":"Efficacy, tolerability and safety of low dose and high dose baclofen in the treatment of alcohol dependence: a systematic review and meta-analysis","volume":"28","author":"Pierce","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.02.010_bib0037","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/alcalc\/agz026","article-title":"Clinical predictors of response to baclofen in the treatment of alcohol use disorder: results from the BacALD trial","volume":"54","author":"Rombouts","year":"2019","journal-title":"Alcohol Alcohol"},{"issue":"8","key":"10.1016\/j.euroneuro.2021.02.010_bib0038","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/add.14191","article-title":"Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis","volume":"113","author":"Rose","year":"2018","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.02.010_bib0039","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopsych.2006.04.038","article-title":"Anticipation of aversive visual stimuli is associated with increased insula activation in anxiety-prone subjects","volume":"60","author":"Simmons","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.02.010_bib0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1037\/0021-843X.91.3.199","article-title":"Alcohol dependence syndrome: measurement and validation","volume":"91","author":"Skinner","year":"1982","journal-title":"J. Abnorm. Psychol."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.02.010_bib0041","doi-asserted-by":"crossref","first-page":"414","DOI":"10.35946\/arcr.v34.4.06","article-title":"Anxiety and alcohol use disorders: comorbidity and treatment considerations","volume":"34","author":"Smith","year":"2012","journal-title":"Alcohol Res."},{"key":"10.1016\/j.euroneuro.2021.02.010_bib0042","series-title":"Timeline Follow-Back. Measuring Alcohol Consumption: Psychosocial and Biochemical Methods","first-page":"41","author":"Sobell","year":"1992"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.02.010_bib0043","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuroimage.2010.11.062","article-title":"Effects of alcohol on brain responses to social signals of threat in humans","volume":"55","author":"Sripada","year":"2011","journal-title":"Neuroimage"},{"issue":"11","key":"10.1016\/j.euroneuro.2021.02.010_bib0044","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br. J. Addict"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.02.010_bib0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/WNP.0000000000000377","article-title":"Structure and function of the human insula","volume":"34","author":"Uddin","year":"2017","journal-title":"J. Clin. Neurophysiol."},{"issue":"6","key":"10.1016\/j.euroneuro.2021.02.010_bib0046","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: the PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J. Pers Soc. Psychol."},{"key":"10.1016\/j.euroneuro.2021.02.010_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102162","article-title":"Brain activation and subjective anxiety during an anticipatory anxiety task is related to clinical outcome during prazosin treatment for alcohol use disorder","volume":"26","author":"Wilcox","year":"2020","journal-title":"Neuroimage Clin."},{"issue":"12","key":"10.1016\/j.euroneuro.2021.02.010_bib0048","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/acer.12187","article-title":"Altered neural processing of threat in alcohol-dependent men","volume":"37","author":"Yang","year":"2013","journal-title":"Alcohol Clin. Exp. Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:59:04Z","timestamp":1760378344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X21001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":48,"alternative-id":["S0924977X21001449"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.02.010","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}